TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
NACIA Biotechnology AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2021/12 | 2020/12 |
| Turnover |
0
|
0
|
30 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-20
|
-2
|
-4 |
| EBITDA |
-20
|
-2
|
-4 |
| Total assets |
225
|
247
|
252 |
| Current assets |
225
|
247
|
252 |
| Current liabilities |
252
|
249
|
251 |
| Equity capital |
-27
|
-1
|
1 |
| - share capital |
9
|
10
|
10 |
| Employees (average) |
2
|
2
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2021/12 | 2020/12 |
| Solvency |
-12.0%
|
-0.4%
|
0.4% |
| Turnover per employee |
0
|
0 | |
| Profit as a percentage of turnover | -13.3% | ||
| Return on assets (ROA) |
-8.9%
|
-0.8%
|
-1.6% |
| Current ratio |
89.3%
|
99.2%
|
100.4% |
| Return on equity (ROE) |
74.1%
|
200%
|
-400% |
| Change turnover |
0
|
-29
|
30 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
0
|
2
|
-2 |
| Chg. No. of employees % | 0% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.